Carson Allaria Wealth Management, Ltd. Sarepta Therapeutics, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 50 shares of SRPT stock, worth $5,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 76
34.21%
Holding current value
$5,711
Previous $12,000
50.0%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.02 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$715 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$498 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$488 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...